Search

Search Constraints

You searched for: Author/Creator Djandji, Michel

Search Results

1. 166 Efficacy of Dupilumab in Children With Uncontrolled, Moderate-to-Severe Type 2 Asthma, With and Without Evidence of Allergy Enrolled in Phase 3 VOYAGE. (11th October 2021)

2. Dupilumab efficacy and safety in Latin American patients with uncontrolled, moderate-to-severe asthma: phase 3 LIBERTY ASTHMA QUEST study. (4th May 2023)

3. Dupilumab efficacy in subgroups of type 2 asthma with high-dose inhaled corticosteroids at baseline. (October 2022)

5. Montelukast as Add-On Therapy with Inhaled Corticosteroids or Inhaled Corticosteroids and Long-Acting Beta-2-Agonists in the Management of Patients Diagnosed with Asthma and Concurrent Allergic Rhinitis (The RADAR Trial). (2009)